ARCHIVES

ACS Study Shows Reduced Mortality For Low T/N Brands

This article is from The Cancer Letter archive.

Vol. 06 No. 16 | April 18, 1980

Download PDF Visit The Full Archive

Related Articles

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

December 14, 2001

Rosenberg Team May Have Cloned Melanoma Gene

May 31, 1991

Senate Increases NIH Funding for 2013, Rejects President’s $200+ Million Increase for Program Evaluation Activities

June 22, 2012

In Brief: House Hearing On NCI Budget Is March 16; NIH Reauthorization Sent To Senate Floor

February 14, 1992

Cancer Panel Report Urges Removal Of Barriers To Care.

December 7, 2001

Schering to Pay $435M to Settle Federal Charges.

January 26, 2007